AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
0.1300
0.00 (0.00%)
At close: Nov 5, 2026
AccuStem Sciences Market Cap
AccuStem Sciences has a market cap or net worth of $2.09 million as of November 5, 2026. It is the 47,812th most valuable company in the world and the 6,364th biggest in the United States. Its market cap has decreased by 87.00% in one year.
Market Cap
2.09M
Enterprise Value
2.14M
Revenue
98.40K
Global Rank
Country Rank
#6,364 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since March 2, 2022, AccuStem Sciences's market cap has decreased from 20.42M to 2.09M, a decrease of -89.77%. That is a compound annual growth rate of -38.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 2.09M | -84.02% |
| Dec 31, 2025 | 13.07M | 157.22% |
| Dec 31, 2024 | 5.08M | -28.40% |
| Dec 29, 2023 | 7.10M | -53.62% |
| Dec 30, 2022 | 15.31M | -25.04% |
| Mar 2, 2022 | 20.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pacific Software | 3.06M |
| Abpro Holdings | 2.85M |
| Emmaus Life Sciences | 2.81M |
| GPL Holdings | 2.56M |
| Bioxytran | 2.42M |
| CASI Pharmaceuticals | 2.16M |
| America Great Health | 2.12M |
| Nymox Pharmaceutical | 2.10M |